RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Takashi Matsui to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Takashi Matsui has written about Carcinoma, Non-Small-Cell Lung.
Takashi Matsui
Connection Strength
0.202
Carcinoma, Non-Small-Cell Lung
  1. Inoue Y, Inui N, Karayama M, Asada K, Fujii M, Matsuura S, Uto T, Hashimoto D, Matsui T, Ikeda M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy. Cancer Immunol Immunother. 2023 Aug; 72(8):2717-2728.
    View in: PubMed
    Score: 0.202
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support